SUMMARY Recent findings suggest that supplemental calcium could lower the abnormally high proliferation rate found in the colonic mucosa of subjects at high risk for colon cancer. In this double blind controlled study, this effect in volunteers previously operated upon for a colorectal adenocarcinoma was tested. Thirty subjects were randomised to receive either elemental calcium 1200 mg/day or a placebo. Mucosal proliferation was measured with tritiated thymidine labelling before and after the 30 day intervention period. Diets, faecal pH and the concentration of calcium and bile acids in the aqueous phase of feaces were also measured. Labelling index did not differ significantly in the two groups before intervention (placebo 4 0(2 4) v calcium 4 9(2 9), but the difference approached significance afterwards (4 4(2-4) v 6 5(3 4), p=006). Individual changes occurring with intervention were tabulated and comparison of the means for the groups was not significant (A=0-3 vs A=1-8, p=011). Calcium concentration, faecal pH and deoxycholic acid concentration increased in the calcium group (p=0.02, 0 005 and 0 004 respectively). Calcium does not show any effect in decreasing colonic mucosal proliferation in this high risk group for colon cancer; it may increase faecal pH and the production of deoxycholic acid in the colon.
Colorectal cancer remains a leading cause of cancer related deaths in North America and no major change in incidence has been reported over the last decade. Environmental factors are suspected of playing an aetiological role in this disease; in particular, high fat consumption has been under scrutiny. - One proposed mechanism explaining the effect of fat is an increase in bile acid secretion' which subsequently leads to a rise in concentration of potentially toxic secondary bile acids in the colonic lumen.7 This hypothesis is supported by animal experiments showing that these compounds can induce mucosal cell damage, increase proliferation rates"3 and enhance carcinogenesis by acting as tumour promoters"' and by field studies showing that high risk populations for colon cancer have higher concentrations of bile acids in their stools.31112
In animals, calcium was shown to inhibit colonic mucosal damage induced by bile acids under various experimental conditions"-"' presumably by reacting with the acidic lipids to form insoluble and biologically inactive calcium soaps. 14 [17] [18] [19] . These observations have led some to speculate that calcium could affect the human colon in a similar manner and, possibly, decrease the risk for colon cancer.'6 Some investigators showed a protective effect against the disease"' while others observed no association."' Two recent studies, however using human colonic biopsies from high risk individuals suggested a decrease in mucosal cell proliferation or labelling index (LI) -a proposed measure for assessing cancer risk" -after the administration of calcium supplements. '324 In this randomised double blind controlled study, we investigated the effect of supplemental calcium on mucosal proliferation assessed by tritiated thymidine labelling in patients previously operated was 1200 mg/day. The intervention period lasted 30 days. All volunteers were asked to stay on their regular diet. Before and after intervention (day 0 and 30), they underwent a sigmoidoscopic examination without preparation during which three rectal biopsies were taken 10-15 cm from the anal verge; they also provided a stool sample which was immediately frozen. One exception was a colostomy patient in whom the biopsies were taken 10-15 cm from the colostomy opening. Each volunteer was provided with capsules for 30 days with instructions for taking them. Also, sets of three-day food records were taken before intervention and on the last three days of supplementation. Those few who could not attend the scheduled return visit were rescheduled for the earliest available day and were provided with additional capsules. Compliance to the assigned regimen was assessed by pill count and measurement of calcium concentration in the aqueous phase of stools (see Laboratory analysis). The study was approved by the Human Subject Committee of the University of Toronto.
LABORATORY ANALYSIS Labelling index technique and measurement
The biopsies were immersed in 15 ml medium (alphaminimal essential medium minus RNA DNA + 10% fetal calf serum + penicillin-streptomycin (Gibco 600-5070)dil 1/100 in medium). They were cleaned under a dissecting microscope and transferred into 2 ml sterile septum fitted vials (Varian, no. 96-0000 99-00) containing 1t2 ml medium. No more than two biopsies were placed into any one vial. 
Results
Both groups were similar with respect to sex distribution, age, weight, body mass index (weight/ height') and stage of disease at surgery. The placebo group was taller, however (Table 1 ). The groups were not compared for the type of operation performed. Mean daily food intakes before intervention were comparable in terms of percentages of total calories derived from fat, protein, carbohydrate and on the amounts of fibre and starch consumed (Table  2) . Overall, the placebo group consumed more calories and calcium but only the former showed a statistically significant difference. After intervention, the groups remained essentially similar in their dietary intakes according to those same variables.
Compliance was assessed by pill count on the return visit. On the average 98% of the pills were taken in the placebo group while 95% were taken in the calcium group with a mean intervention time of 32.3 days (range 27-38). We also measured calcium concentration in the aqueous phase of faeces. As expected, there was a marked increase in the calcium group after intervention (from 4-77 mmol/l preintervention to 7.94 mmol/l postintervention, p=0-0t) while no difference was apparent in the placebo group (from 5 04 mmol/l to 5-36 mmol/l) and comparison of the changes (A) was significant (p= 0-02).
Labelling index for the two groups was comparable before intervention (Table 3) . After supplementation, however, LI was higher in the calcium group (p=0.06). Thus, cell proliferation was unaffected by intervention in the placebo group while there was a significant increase in the calcium group (p=005) (Fig. 1) . Nevertheless, when these changes (A and A) with intervention were compared, they were found not to be significantly different (p=0-l1) in LI were not compared for the various types of colonic resection -that is, right hemicolectomy, etc, because the small number of individuals in each subgroup would have made the results difficult to interpret. For faecal pH, there was no difference between the two groups before intervention but a significant increase was noted in the calcium group after supplementation (p=003) whereas there was a decrease in the placebo (p=0-07). Comparing these changes, the increase in the calcium group was significantly larger than in the placebo group (p=0005) ( Table 3 ).
The aqueous phase of stool samples was analysed for bile acids. Total bile acid concentrations were similar for both groups before and after intervention. For deoxycholic acid, there was an increase in concentration in the calcium group after intervention (p=0'07) while there was a decrease in the placebo group (p=0-02). Comparison of those changes showed a significant difference at p=0004. 
Discussion
Calcium has become a nutrient of major interest in today's nutrition oriented society. Supplementation with up to 1500 mg/day has been recommended for postmenopausal women to prevent osteoporosis34 although not everyone agrees on its efficacy.3m Two papers from the same research group recently showed a reduction in mucosal cell proliferation of subjects at high risk for colon cancer after calcium supplementation'234 suggesting another possible beneficial effect. In the present study, we tested the effect of supplemental calcium (1200 mg/day) in a different high risk group that is patients previously operated upon for the disease. Before treatment individuals with this malignancy have been shown to have higher cell proliferation in the colonic mucosa using tritiated thymidine labelling (LI)22 than normal subjects. Our goal was thus to use this method to determine whether or not supplementing calcium could lower cell replication after curative surgery. We used previously operated cancer patients receiving a placebo as controls because we wanted to study only the effect of calcium and because we wanted to make the groups as comparable as possible with regards to other possibly confounding variables -that is, resection. Indeed, they were similar on most variables studied except for the pre-intervention caloric consumption. This difference could be the result of failure of some of the volunteers to record their whole daily intake.
Our results were different from those of the previous trials. We showed no lowering in LI after calcium supplementation in the calcium group compared with the placebo group. There were major differences between these two studies and ours which could account for the discrepancy in results. First, in Lipkin's study on individuals at high risk for familial colonic cancer,24 patients were selected by virtue of their high LI and there was no control group; therefore, the decrease in LI observed after intervention could merely reflect a natural change over time. Alternatively, the decrease could have resulted from a change in diet during the study period, although the subjects were asked to continue on their conventional diets, but there were no dietary records to exclude this possibility. This last point is important as a high fat intake was shown to increase LI.' Second, in the earlier study, the subjects were given calcium for three months, while we intervened for one month. The effect of calcium on cell proliferation may require the longer period to manifest itself. This seems unlikely, however, as the animal experiments on which both trials were based showed an effect within a few hours. Third, in our study LI was lower than that reported by other investigators' '7 " and that seen in one of our previous studies" for patients with colon cancer. One has to remember that none of the previous work was done with patients who had had their disease resected; in other words, the subjects still had cancer when the biopsies were taken. Colon resection could reduce LI or the tumour could induce changes in cell proliferation in the entire organ which disappear when it is removed. Our 
